According to the latest report by IMARC Group,
titled “Transdermal Drug Delivery Systems Market: Global Industry Trends, Share,
Size, Growth, Opportunity and Forecast 2021-2026”, the global transdermal
drug delivery systems market exhibited moderate growth during 2015-2020.
Looking forward, IMARC Group expects the market to grow at a CAGR of around 6%
during 2021-2026.
We are regularly tracking the direct effect of
COVID-19 on the market, along with the indirect influence of associated
industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/transdermal-drug-delivery-systems-market/requestsample
Transdermal
drug delivery systems involve a painless method of delivering drugs through the
skin systematically. It is a preferred non-invasive alternative to the
parenteral route and oral intravascular mode of drug delivery into the body.
This method involves the penetration of drugs via the stratum corneum, which
passes through the epidermis and dermis without the accumulation of drugs into
the dermal layer of the skin. It is widely utilized for the treatment of chronic
and acute illnesses as well as cosmetic therapies.
The
global market is primarily driven by significant growth in the healthcare
sector. Moreover, continual technological advancements across the industry,
such as the introduction of iontophoresis that facilitates self-administration
of drugs, are creating a positive outlook for the market. The rising
investments by public and private firms to upgrade the existing healthcare
infrastructure are also contributing to the market growth. Other factors,
including the increasing preference for non-invasive treatments among the
masses and extensive research and development (R&D) activities, are
propelling the market growth further.
Transdermal
Drug Delivery Systems Market 2021-2026 Competitive Analysis and
Segmentation:
Competitive
Landscape with Key Players:
The
competitive landscape of the global transdermal drug delivery systems market has
been studied in the report with the detailed profiles of the key players
operating in the market.
Some of these key players include:
·
3M Company
·
Acrux Limited
·
Boehringer Ingelheim
International GmbH
·
Hisamitsu Pharmaceutical Co.
Inc.
·
Lavipharm S.A.
·
LEAD CHEMICAL Co. Ltd.
·
Luye Pharma Group
·
Nutriband Inc.
·
Viatris Inc.
Key Market Segmentation:
The report has segmented the global transdermal
drug delivery systems market on the basis of technology, application and region.
Breakup by Technology:
·
Electroporation
·
Radiofrequency
·
Iontophoresis
·
Microporation
·
Thermal
·
Mechanical Arrays
·
Ultrasound
·
Others
Breakup by Application:
·
Central Nervous System
·
Pain Management
·
Cardiovascular
·
Hormone
·
Others
Breakup by Region:
·
North America
·
Asia-Pacific
·
Europe
·
Latin America
·
Middle East and Africa
Explore Full Report with TOC & List of
Figure: https://www.imarcgroup.com/transdermal-drug-delivery-systems-market
Key
highlights of the report:
- Market
Performance (2015-2020)
- Market
Outlook (2021-2026)
- Industry
Trends
- Market
Drivers and Success Factors
- The
Impact of COVID-19 on the Global Market
- Value
Chain Analysis
- Structure
of the Global Market
- Comprehensive
mapping of the competitive landscape
If you
need specific information that is not currently within the scope of the report,
we will provide it to you as a part of the customization.
Browse Related Reports:
About Us
IMARC
Group is a leading market research company that offers management strategy and
market research worldwide. We partner with clients in all sectors and regions
to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s
information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial,
and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa:
+44-753-713-2163 | Asia: +91-120-433-0800
No comments:
Post a Comment